210 related articles for article (PubMed ID: 31883847)
21. Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy.
Ball T; Sperr WR; Valent P; Lidholm J; Spitzauer S; Ebner C; Kraft D; Valenta R
Eur J Immunol; 1999 Jun; 29(6):2026-36. PubMed ID: 10382766
[TBL] [Abstract][Full Text] [Related]
22. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
[TBL] [Abstract][Full Text] [Related]
23. Evolution of IgM, IgE and IgG(1-4 )antibody responses in early childhood monitored with recombinant allergen components: implications for class switch mechanisms.
Niederberger V; Niggemann B; Kraft D; Spitzauer S; Valenta R
Eur J Immunol; 2002 Feb; 32(2):576-84. PubMed ID: 11828375
[TBL] [Abstract][Full Text] [Related]
24. Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy.
Aasbjerg K; Backer V; Lund G; Holm J; Nielsen NC; Holse M; Wagtmann VR; Würtzen PA
Clin Exp Allergy; 2014 Mar; 44(3):417-28. PubMed ID: 24734285
[TBL] [Abstract][Full Text] [Related]
25. Induction of IgG
Heeringa JJ; McKenzie CI; Varese N; Hew M; Bakx ATCM; Aui PM; Rolland JM; O'Hehir RE; van Zelm MC
Allergy; 2020 May; 75(5):1121-1132. PubMed ID: 31587307
[TBL] [Abstract][Full Text] [Related]
26. Essential role of macrophages in the initiation of allergic rhinitis in mice sensitized intranasally once with cedar pollen: regulation of class switching of immunoglobulin in B cells by controlling interleukin-4 production in T cells of submandibular lymph nodes.
Hirano M; Ogita-Nakanishi H; Miyachi W; Hannya N; Yamamoto-Kimoto Y; Sakurai K; Miyoshi-Higashino M; Tashiro-Yamaji J; Kato R; Ijiri Y; Tanaka K; Kanazawa A; Terada T; Kawata R; Takenaka H; Kubota T; Yoshida R
Microbiol Immunol; 2012 Jun; 56(6):392-405. PubMed ID: 22404751
[TBL] [Abstract][Full Text] [Related]
27. Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.
Mothes N; Heinzkill M; Drachenberg KJ; Sperr WR; Krauth MT; Majlesi Y; Semper H; Valent P; Niederberger V; Kraft D; Valenta R
Clin Exp Allergy; 2003 Sep; 33(9):1198-208. PubMed ID: 12956739
[TBL] [Abstract][Full Text] [Related]
28. Poor association of allergen-specific antibody, T- and B-cell responses revealed with recombinant allergens and a CFSE dilution-based assay.
Eckl-Dorna J; Campana R; Valenta R; Niederberger V
Allergy; 2015 Oct; 70(10):1222-9. PubMed ID: 26043182
[TBL] [Abstract][Full Text] [Related]
29. Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial.
Chaker AM; Shamji MH; Dumitru FA; Calderon MA; Scadding GW; Makatsori M; Jones I; He QA; Subramanian KK; Arm JP; Durham SR; Schmidt-Weber CB
J Allergy Clin Immunol; 2016 Feb; 137(2):452-461.e9. PubMed ID: 26531865
[TBL] [Abstract][Full Text] [Related]
30. Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy.
Van Overtvelt L; Baron-Bodo V; Horiot S; Moussu H; Ricarte C; Horak F; Zieglmayer P; Zieglmayer R; Montagut A; Galvain S; de Beaumont O; Le Gall M; Moingeon P
Allergy; 2011 Dec; 66(12):1530-7. PubMed ID: 21883279
[TBL] [Abstract][Full Text] [Related]
31. Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen.
Rolinck-Werninghaus C; Kopp M; Liebke C; Lange J; Wahn U; Niggemann B
Int Arch Allergy Immunol; 2005 Feb; 136(2):134-41. PubMed ID: 15650310
[TBL] [Abstract][Full Text] [Related]
32. Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cells.
Mascarell L; Rak S; Worm M; Melac M; Soulie S; Lescaille G; Lemoine F; Jospin F; Paul S; Caplier L; Hasséus B; Björhn C; Zeldin RK; Baron-Bodo V; Moingeon P
Allergy; 2015 Apr; 70(4):408-19. PubMed ID: 25631199
[TBL] [Abstract][Full Text] [Related]
33. Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: a study performed with purified recombinant pollen allergens.
Aghayan-Ugurluoglu R; Ball T; Vrtala S; Schweiger C; Kraft D; Valenta R
J Allergy Clin Immunol; 2000 Apr; 105(4):803-13. PubMed ID: 10756233
[TBL] [Abstract][Full Text] [Related]
34. Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial.
Sharif H; Singh I; Kouser L; Mösges R; Bonny MA; Karamani A; Parkin RV; Bovy N; Kishore U; Robb A; Katotomichelakis M; Holtappels G; Derycke L; Corazza F; von Frenckell R; Wathelet N; Duchateau J; Legon T; Pirotton S; Durham SR; Bachert C; Shamji MH
J Allergy Clin Immunol; 2019 Sep; 144(3):738-749. PubMed ID: 30844425
[TBL] [Abstract][Full Text] [Related]
35. Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.
Cox LS; Casale TB; Nayak AS; Bernstein DI; Creticos PS; Ambroisine L; Melac M; Zeldin RK
J Allergy Clin Immunol; 2012 Dec; 130(6):1327-34.e1. PubMed ID: 23122534
[TBL] [Abstract][Full Text] [Related]
36. [Interleukin 4, total and allergen-specific immunoglobulin E antibodies in the blood of individuals with an atopic constitution].
Paranos S; Pravica V; Bonaci B; Stojković-Mostarica M
Srp Arh Celok Lek; 1998; 126(3-4):92-6. PubMed ID: 9863362
[TBL] [Abstract][Full Text] [Related]
37. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
38. Antigens drive memory IgE responses in human allergy via the nasal mucosa.
Niederberger V; Ring J; Rakoski J; Jager S; Spitzauer S; Valent P; Horak F; Kundi M; Valenta R
Int Arch Allergy Immunol; 2007; 142(2):133-44. PubMed ID: 17057411
[TBL] [Abstract][Full Text] [Related]
39. Allergens. Heterogeneity of molecular sensitization profiles in grass pollen allergy--implications for immunotherapy?
Darsow U; Brockow K; Pfab F; Jakob T; Petersson CJ; Borres MP; Ring J; Behrendt H; Huss-Marp J
Clin Exp Allergy; 2014; 44(5):778-86. PubMed ID: 24598010
[TBL] [Abstract][Full Text] [Related]
40. The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses.
Shamji MH; Wilcock LK; Wachholz PA; Dearman RJ; Kimber I; Wurtzen PA; Larché M; Durham SR; Francis JN
J Immunol Methods; 2006 Dec; 317(1-2):71-9. PubMed ID: 17070537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
